IMDX
Insight Molecular Diagnostics
IMDX
IMDX
88 hedge funds and large institutions have $120M invested in Insight Molecular Diagnostics in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 28 increasing their positions, 31 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
7% less funds holding
Funds holding: 95 → 88 (-7)
35% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 17
40% less capital invested
Capital invested by funds: $201M → $120M (-$81.2M)
Holders
88
Holding in Top 10
2
Calls
$626K
Puts
$88K
Top Buyers
| 1 | +$1.38M | |
| 2 | +$1.35M | |
| 3 | +$556K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$547K |
| 5 |
Morgan Stanley
New York
|
+$351K |
Top Sellers
| 1 | -$2.78M | |
| 2 | -$2.19M | |
| 3 | -$1.03M | |
| 4 |
Two Sigma Investments
New York
|
-$848K |
| 5 |
Two Sigma Advisers
New York
|
-$789K |